Investing in GSK
GSK is currently the largest healthcare company in the UK with offices in more than 100 countries and major research centres in the UK, USA, Belgium and China. In recent years, GSK has focused its business around three strategic priorities which aim to increase growth, reduce risk and improve long-term financial performance.
As a global healthcare company, our commercial success depends on creating innovative new medicines, vaccines and healthcare products and making these accessible to as many people who need them as possible. 2012 was characterised by a challenging global economic climate. Despite this, we have continued to make good progress in our strategy to grow our business in a sustainable way, deliver new medicines and healthcare products that are valued by those who use them, and simplify our operations.
We are committed to using free cash flow to support increasing dividends, share repurchases or, where returns are more attractive, bolt-on acquisitions.
Discover more...
Our businesses
Find out about our three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare, and also about the value we place on R&D.
Our performance
Find out about our sales performance, shareholder returns and productivity.
Financial architecture
Information on our new financial architecture which we established in 2011.